Author Correction: Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

Affiliations

• ¹ Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
• ² Division of Hematology, University of Utah School of Medicine, Salt Lake City, UT, USA.
• ³ Systems Immunity Research Institute, Cardiff University, Cardiff, UK.
• ⁴ Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.
• ⁵ Center for Cancer Immune Therapy, Herlev Hospital, Copenhagen University, Copenhagen, Denmark.
• ⁶ Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
• ⁷ Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia.
• ⁸ Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
• ⁹ Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK. [email protected].
• ¹⁰ Systems Immunity Research Institute, Cardiff University, Cardiff, UK. [email protected].